GLP Watchdog

Embody vs Gala

Neither Embody nor Gala has an FDA warning letter on record. On compounded semaglutide injection, Embody costs $1,200 less a year at standing rates: $79 a month against $179 a month at Gala. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Embody / Gala

Embody logo

Embody

9.3/10

Gala logo

Gala

8.5/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$79/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
All 50 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Embody
Visit Gala

Both Embody and Gala are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Embody 9.3, Gala 8.5). How we are paid

What the record shows

  1. 01

    Neither Embody nor Gala has an FDA warning letter on record.

  2. 02

    Embody names four pharmacies. Gala names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Embody costs $1,200 less a year at standing rates: $79 a month against $179 a month at Gala. It is one of two products the two sell at comparable terms.

  4. 04

    Only Embody lists a price for compounded oral tirzepatide. Only Gala lists a price for brand-name semaglutide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Embody

Gala

Compounded semaglutide injection

$79/moLower

$948 a year

$179/mo

$2,148 a year

Compounded tirzepatide injection

$129/moLower

$1,548 a year

$179/mo

$2,148 a year

Brand-name semaglutide pen
Not sold or not priced

$1,299/mo

$15,588 a year

Compounded oral tirzepatide

$329/mo

$3,948 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the one-month plan; 3-, 6- and 12-month plans are prepaid
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
Refunds
No refunds once paid; a partial refund only after a medical disqualification
No refund on cancellation; full refund only if the medical provider disqualifies you
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Embody: October 30, 2026. Gala: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Embody

9.3/10
  • $1,200 a year less on compounded semaglutide injection
  • $600 a year less on compounded tirzepatide injection
  • Sells compounded oral tirzepatide, which Gala does not price
  • Names its compounding pharmacy
Visit Embody

The case for Gala

8.5/10
  • Sells brand-name semaglutide pen, which Embody does not price
  • Names no compounding pharmacy
Visit Gala

Scores

Embody 9.3 · Gala 8.5 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
7.9

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
7.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Embody vs Gala: questions

Neither Embody nor Gala has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Embody names four pharmacies. Gala names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Embody, by $1,200 a year at standing rates. Embody: $79 a month, about $948 a year. Gala: $179 a month, about $2,148 a year.
Embody states you can cancel at any time; refunds: no refunds once paid; a partial refund only after a medical disqualification. Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you.
Both Embody and Gala are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Embody 9.3, Gala 8.5).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks